6155 related articles for article (PubMed ID: 3430796)
1. [Subungual amelanotic superficial spreading melanoma: a case diagnosed with mouse monoclonal antibodies against human melanosome-associated antigens (HMSA)].
Yamana K; Maeda K; Akutsu Y; Jimbow K
Nihon Hifuka Gakkai Zasshi; 1987 Aug; 97(9):1015-23. PubMed ID: 3430796
[No Abstract] [Full Text] [Related]
2. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma.
Akutsu Y; Jimbow K
Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
Kageshita T; Ishihara K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
[TBL] [Abstract][Full Text] [Related]
4. Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma.
Maeda K; Maeda K; Jimbow K
Cancer; 1988 Sep; 62(5):926-34. PubMed ID: 3044572
[TBL] [Abstract][Full Text] [Related]
5. Melan A (MART-1): a new monoclonal antibody for malignant melanoma diagnosis.
Orchard GE
Br J Biomed Sci; 1998 Mar; 55(1):8-9. PubMed ID: 9684410
[No Abstract] [Full Text] [Related]
6. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
Fukaya T
Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic meningitis in malignant melanoma: diagnosis with monoclonal antibodies.
Moseley RP; Davies AG; Bourne SP; Popham C; Carrel S; Monro P; Coakham HB
J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):881-6. PubMed ID: 2671265
[TBL] [Abstract][Full Text] [Related]
9. Development of MoAb HMSA-3 and HMSA-4 against human melanoma melanosomes and their reactivities on formalin-fixed melanoma tissues.
Maeda K; Yamana K; Jimbow K
J Invest Dermatol; 1987 Dec; 89(6):588-93. PubMed ID: 3680982
[TBL] [Abstract][Full Text] [Related]
10. The impact of monoclonal antibodies on the study of human malignant melanoma.
Natali PG; Aguzzi A; Veglia F; Imai K; Burlage RS; Giacomini P; Ferrone S
J Cutan Pathol; 1983 Dec; 10(6):514-28. PubMed ID: 6198345
[No Abstract] [Full Text] [Related]
11. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
[TBL] [Abstract][Full Text] [Related]
13. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
14. Melanoma antigens: immunological and biological characterization and clinical significance.
Herlyn M; Koprowski H
Annu Rev Immunol; 1988; 6():283-308. PubMed ID: 3289568
[No Abstract] [Full Text] [Related]
15. Characterization of melanosome-associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti-melanosome antibody.
Dakour J; Jimbow K; Vinayagamoorthy T; Luo D; Chen H
Melanoma Res; 1993 Oct; 3(5):331-6. PubMed ID: 8292889
[TBL] [Abstract][Full Text] [Related]
16. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
17. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
Hwang KM; Fodstad O; Oldham RK; Morgan AC
Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
[TBL] [Abstract][Full Text] [Related]
18. [Immunological analysis of melanoma specific antigen. (I). In-vitro induction of melanoma-antigen specific killer T lymphocytes in primary immune response].
Wakabayashi S; Taniguchi M; Tomioka H; Okamoto S
Nihon Hifuka Gakkai Zasshi; 1983 Dec; 93(14):1469-76. PubMed ID: 6676498
[No Abstract] [Full Text] [Related]
19. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal hybridoma antibodies in human melanoma: current status.
Burk MW
Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
